LivaNova PLC (LIVN) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
53/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinLIVN / S&P 29.37% / 15.20% |
LoseLIVN / S&P 12.39% / 15.00% |
LoseLIVN / S&P -187.11% / 50.40% |
| 2026-Q12/3 |
WinLIVN / S&P 3.30% / -4.33% |
WinLIVN / S&P 12.39% / 11.30% |
LoseLIVN / S&P -147.79% / 27.70% |
| 2025-Q42/3 |
WinLIVN / S&P 17.47% / 2.65% |
WinLIVN / S&P 10.74% / 9.00% |
LoseLIVN / S&P -487.83% / 13.40% |
| 2025-Q32/3 |
WinLIVN / S&P 16.35% / 8.12% |
WinLIVN / S&P 8.63% / 4.61% |
LoseLIVN / S&P -1050.00% / 13.45% |
| 2025-Q23/3 |
WinLIVN / S&P 14.61% / 10.94% |
WinLIVN / S&P 8.23% / 4.83% |
WinLIVN / S&P 1112.50% / 10.63% |
| 2025-Q12/3 |
LoseLIVN / S&P -15.18% / -4.27% |
WinLIVN / S&P 7.62% / 4.98% |
WinLIVN / S&P 580.00% / 10.57% |
| 2024-Q42/3 |
LoseLIVN / S&P -11.86% / 2.41% |
WinLIVN / S&P 8.66% / 5.25% |
WinLIVN / S&P 259.37% / 6.15% |
| 2024-Q32/3 |
LoseLIVN / S&P -4.16% / 5.89% |
WinLIVN / S&P 11.04% / 5.89% |
WinLIVN / S&P 740.00% / 6.11% |
| 2024-Q21/3 |
LoseLIVN / S&P -2.00% / 4.28% |
WinLIVN / S&P 11.52% / 5.38% |
LoseLIVN / S&P -82.42% / 5.12% |
| 2024-Q11/3 |
LoseLIVN / S&P 8.12% / 10.56% |
WinLIVN / S&P 13.40% / 5.71% |
LoseLIVN / S&P -61.04% / 5.59% |
| 2023-Q41/3 |
LoseLIVN / S&P -2.16% / 11.69% |
WinLIVN / S&P 12.89% / 6.81% |
LoseLIVN / S&P -119.75% / 7.78% |
| 2023-Q32/3 |
WinLIVN / S&P 2.82% / -3.27% |
WinLIVN / S&P 9.96% / 7.52% |
LoseLIVN / S&P -102.94% / -5.03% |
| 2023-Q22/3 |
WinLIVN / S&P 18.01% / 8.74% |
LoseLIVN / S&P 6.60% / 9.50% |
WinLIVN / S&P 243.40% / -8.57% |
| 2023-Q10/3 |
LoseLIVN / S&P -21.53% / 7.50% |
LoseLIVN / S&P 1.66% / 10.77% |
LoseLIVN / S&P -22.22% / -15.69% |
| 2022-Q41/3 |
WinLIVN / S&P 9.40% / 7.56% |
LoseLIVN / S&P -1.31% / 11.88% |
LoseLIVN / S&P -39.33% / -17.99% |
| 2022-Q30/3 |
LoseLIVN / S&P -18.73% / -4.88% |
LoseLIVN / S&P -1.73% / 13.47% |
LoseLIVN / S&P -79.91% / -1.41% |
| 2022-Q20/3 |
LoseLIVN / S&P -23.66% / -16.10% |
LoseLIVN / S&P -0.40% / 13.71% |
LoseLIVN / S&P -93.31% / 11.04% |
| 2022-Q10/3 |
LoseLIVN / S&P -6.41% / -4.60% |
LoseLIVN / S&P 9.42% / 15.97% |
LoseLIVN / S&P -76.92% / 42.23% |
| 2021-Q40/3 |
LoseLIVN / S&P 10.41% / 11.03% |
LoseLIVN / S&P 10.82% / 15.00% |
LoseLIVN / S&P -62.81% / 96.40% |
| 2021-Q31/3 |
LoseLIVN / S&P -5.85% / 0.58% |
LoseLIVN / S&P 8.67% / 10.77% |
WinLIVN / S&P 94.48% / 69.42% |
| 2021-Q22/3 |
WinLIVN / S&P 14.08% / 8.55% |
LoseLIVN / S&P 4.17% / 6.58% |
WinLIVN / S&P 133.63% / 51.81% |
| 2021-Q12/3 |
WinLIVN / S&P 11.36% / 6.17% |
LoseLIVN / S&P -12.67% / -1.06% |
WinLIVN / S&P 293.58% / 7.39% |
| 2020-Q42/3 |
WinLIVN / S&P 46.45% / 12.15% |
LoseLIVN / S&P -13.83% / -3.72% |
WinLIVN / S&P 120.25% / -33.42% |
| 2020-Q31/3 |
LoseLIVN / S&P -6.07% / 8.93% |
LoseLIVN / S&P -12.92% / -2.04% |
WinLIVN / S&P -5.23% / -27.10% |
| 2020-Q20/3 |
LoseLIVN / S&P 6.36% / 20.54% |
LoseLIVN / S&P -10.60% / -0.46% |
LoseLIVN / S&P -37.22% / -27.11% |
| 2020-Q10/3 |
LoseLIVN / S&P -40.01% / -19.60% |
LoseLIVN / S&P -2.85% / 3.47% |
LoseLIVN / S&P -51.45% / -14.75% |
| 2019-Q40/3 |
LoseLIVN / S&P 2.22% / 9.07% |
LoseLIVN / S&P -2.06% / 5.36% |
LoseLIVN / S&P -16.62% / 2.99% |
| 2019-Q33/3 |
WinLIVN / S&P 2.54% / 1.70% |
WinLIVN / S&P 20.69% / 5.02% |
WinLIVN / S&P 144.15% / 0.21% |
| 2019-Q22/3 |
LoseLIVN / S&P -26.01% / 4.30% |
WinLIVN / S&P 16.25% / 6.64% |
WinLIVN / S&P 365.52% / 8.65% |
| 2019-Q12/3 |
LoseLIVN / S&P 6.32% / 13.65% |
WinLIVN / S&P 13.28% / 8.12% |
WinLIVN / S&P 816.33% / 14.29% |
| 2018-Q42/3 |
LoseLIVN / S&P -26.22% / -13.52% |
WinLIVN / S&P 16.03% / 9.05% |
WinLIVN / S&P 637.74% / 18.23% |
| 2018-Q31/3 |
WinLIVN / S&P 24.19% / 7.71% |
LoseLIVN / S&P -1.45% / 10.21% |
LoseLIVN / S&P -260.68% / 19.06% |
| 2018-Q21/3 |
WinLIVN / S&P 12.79% / 3.43% |
LoseLIVN / S&P 4.27% / 9.03% |
LoseLIVN / S&P -303.51% / 14.46% |
| 2018-Q13/3 |
WinLIVN / S&P 10.74% / -0.76% |
WinLIVN / S&P 8.05% / 7.68% |
WinLIVN / S&P 113.04% / 12.46% |
| 2017-Q41/3 |
WinLIVN / S&P 14.07% / 6.64% |
LoseLIVN / S&P -1.13% / 7.03% |
LoseLIVN / S&P -58.91% / 13.82% |
| 2017-Q31/3 |
WinLIVN / S&P 14.46% / 4.48% |
LoseLIVN / S&P -5.29% / 5.68% |
LoseLIVN / S&P -171.34% / 17.57% |
| 2017-Q22/3 |
WinLIVN / S&P 24.89% / 3.09% |
WinLIVN / S&P 33.98% / 4.83% |
LoseLIVN / S&P -135.85% / 17.74% |
| 2017-Q12/3 |
WinLIVN / S&P 8.98% / 6.07% |
WinLIVN / S&P 94.81% / 3.67% |
LoseLIVN / S&P -74.73% / 13.32% |
| 2016-Q40/3 |
LoseLIVN / S&P -25.19% / 3.82% |
LoseLIVN / S&P LIVN unavailable / 2.09% |
LoseLIVN / S&P LIVN unavailable / 7.05% |
| 2016-Q31/3 |
WinLIVN / S&P 19.67% / 3.85% |
LoseLIVN / S&P LIVN unavailable / 0.20% |
LoseLIVN / S&P LIVN unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | LIVN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 41.97% | 20.78% |
| Annualized return | 41.97% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | LIVN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -4.35% | 83.14% |
| Annualized return | -0.89% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | LIVN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 32.92% | 319.30% |
| Annualized return | 2.89% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |